WashU, Eisai form drug discovery collaboration
The School of Medicine and pharmaceutical company Eisai Co. Ltd. have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease and other neurodegenerative conditions.
Exercise, mindfulness don’t appear to boost cognitive function in older adults
A large study conducted in part by School of Medicine researchers focused on whether exercise and mindfulness training could boost cognitive function in older adults. The study found no such improvement following the interventions.
Theunissen named to editorial board of early-career scientists
Thorold Theunissen, at the School of Medicine, has been named to an editorial board of early-career scientists for the journal Stem Cell Reports.
Researchers awarded $1.2M to study depression among youth with HIV in Uganda
Proscovia Nabunya, at the Brown School; and Patricia Cavazos-Rehg, at the School of Medicine, have received a five-year $1.2 million research grant from the National Institute of Mental Health, part of the National Institutes of Health (NIH), to address depression among youth living with HIV in Uganda.
WashU’s nasal COVID-19 vaccine approved for use as booster in India
A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines.
Genin, Guilak named to National Academy of Inventors
The National Academy of Inventors has elected two Washington University faculty members to its 2022 cohort of fellows: Guy Genin, at the McKelvey School of Engineering, and Farshid Guilak, at the School of Medicine.
Evidence of autoimmunity’s origins uncovered via new approach
A study involving School of Medicine researchers supports the idea that some T cells that react to microbes also may react to normal human proteins, causing autoimmune disease. The findings promise to accelerate efforts to improve diagnostic tools and treatments for autoimmune diseases.
Some forms of childhood malnutrition, stunting may be preventable with vaccines
Researchers at the School of Medicine have discovered that vaccinating mice against a bacterial toxin produced by E. coli can prevent intestinal damage. The finding suggests new ways to prevent malnutrition and stunting in children.
Study supports urging smoking-cessation treatment to patients in cancer care
A nationwide team studied 44,000 smokers at 28 cancer centers, including Siteman Cancer Center, and learned that if they could get such patients into nicotine replacement, counseling or both, they could help nearly one in five quit smoking, while also boosting cancer survival rates.
Immunotherapy eliminates disease-causing cells in mice with MS-like disease
School of Medicine scientists have shown that the cancer therapy known as CAR-T can be applied to multiple sclerosis (MS), an autoimmune disease of the nervous system. The findings extend the powerful tool of immunotherapy to autoimmune diseases, a class of diseases that are often debilitating and difficult to treat.
View More Stories